The Epidemiology and Economics of Intervertebral Disc Disease

1 The Epidemiology and Economics of Intervertebral Disc Disease


Maneesh Bawa and Scott D. Boden


Epidemiology


Epidemiology refers to the study of occurrence rates and provides important insights into understanding intervertebral disc (IVD) disease. It provides information about the natural history of a disease so patient counseling about prognosis and appropriate treatment recommendations can be made. It also helps establish associations between a disease and individual or external factors, which allow risk factors to be identified. Finally, it provides information on the demand for social and medical resources, which is important for formulating public health policies.


Epidemiologic research on back disorders is difficult for several reasons. First, there is no standard definition of disc degeneration, so comparisons between studies are difficult because each study defines disc degeneration differently. Second, measures of disc degeneration often lack reliability and precision. Third, accurate measures of lifetime exposures, such as vibration or physical loading, are impossible. Finally, disc degeneration and back pain are not synonymous. Pain is a symptom, whereas the definition of disc degeneration varies with the method used to evaluate the disc; for example, radiographic versus biochemical. Disc degeneration is commonly thought to be associated with severe symptoms and is often targeted diagnostically and therapeutically, but most of the findings associated with disc degeneration, such as desiccation, osteophytes, and disc narrowing, have unclear mechanisms in pain production. Indeed, there is a large body of research into the mechanisms of pain production, but a clear understanding of how the disc causes pain has yet to be gained.


Recently, our views on the etiology of disc degeneration have been changing given our new understanding of genetic influences. Disc degeneration is the result of lifetime degradation and remodeling of both the vertebrae and the disc in response to physical loading and healing. This traditional view of disc degeneration was espoused by Frymoyer1 in 1992, “Among the factors associated with its occurrence are age, gender, occupation, cigarette smoking, and exposure to vehicular vibration.” Therefore, most attention has been given to environmental exposures as risk factors. Only recently have studies been conducted on the hereditary aspects of disc degeneration, and they are dramatically changing the earlier concepts. In one review of current scientific literature, the authors noted that environmental factors may explain only a small portion of disc degeneration and concluded that “genetic factors play an important role in disc pathology, and perhaps a major one.”2


Defining Disc Degeneration


Definitions of disc degeneration have not been uniform because the process is not well understood. Usually, it is largely defined by the modality used to evaluate it. Radiographic data, autopsy results, surgical samples, biochemical analyses, and microscopic evaluation have all been used in different studies to try to define degeneration. Currently, the preferred method of evaluating the disc for large population samples is magnetic resonance imaging (MRI). There are various qualitative measures of disc degeneration, such as disc space narrowing, desiccation, bulging, and signal intensity loss, to name a few. There are various scales to try to quantify these qualitative changes, but comparisons between studies are often limited because of suboptimal reliability, imprecision, and lack of uniformity of assessments.


Thompson et al3 provided the first grading scheme for gross morphology of the disc using 15 cadaveric specimens. Once MRI became more widely accepted, disc space narrowing was the most commonly used criterion. Severe narrowing is an obvious sign of degeneration, but early changes in the disc do not always cause narrowing.4 If changes in the neighboring vertebrae are taken into account, including vertebral rim osteophytes and concavity of the endplates, disc height actually increases initially, and measurements of disc volume may be more important.5 Other commonly evaluated findings on MRI include Schmorl’s nodes, herniations, bulges, vertebral rim osteophytes, disc signal intensity, and high-intensity zones with annular tears. Many studies calculate a summary score to try to take all these findings into account, but this may mask specific effects and miss important correlations, especially genetic ones.2


Prevalence of Disc Degeneration


Battie et al2 performed a thorough review of the scientific literature regarding MRI findings associated with disc degeneration. They identified 20 studies that included information on “asymptomatic” subjects and 10 studies that reported on populations that were symptomatic. As expected, the reported prevalences varied widely between studies. The reported prevalences for asymptomatic subjects were 10 to 81% for bulges, 3 to 63% for protrusion, 0 to 24% for extrusion, 20 to 83% for reduction in signal intensity, 3 to 56% for disc narrowing, 6 to 56% for high-intensity zones with annular tears, and 8 to 19% for Schmorl’s nodes. The corresponding prevalences for the symptomatic population were 22 to 48% for bulges, 0 to 79% for protrusion, 1 to 55% for extrusion, 9 to 86% for reduction in signal intensity, 15 to 53% for disc narrowing, 15% for high-intensity zones with annular tears, and 6 to 79% for Schmorl’s nodes. The authors concluded that there was no clear difference between the ranges reported for the two groups. Variations in the reported prevalence ranges could be due to age, exposure to known and unknown risk factors, or the disc levels included, but much of the variation is probably due to the different definitions of degenerative changes in the studies.


Many studies do not report prevalences by the specific level, but report summary scores that include the entire lumbar spine. This is problematic because large variations in prevalence have been reported based on the level of the lumbar spine, and the effect of risk factors could vary by level. Schmorl’s nodes are most common in the upper levels (L1-L3), while degenerative changes are most common in the lower levels (L4-S1). Between L1 and L3, degenerative changes were uncommon (0 to 14%), whereas between L4 and S1, disc narrowing occurred 20 to 37%, disc bulges 5 to 33%, protrusions 10 to 32%, extrusions 3 to 47%, and annular tears 0 to 20%.2 Disc herniations are most common at the thoracolumbar and lumbosacral junctions. Therefore, studies that summarize degenerative findings over the entire lumbar spine may miss important differences that are level specific.


Risk Factors


Age and Gender

The risk factor studied most intensely in relation to the degenerative process has been age. Numerous studies involving both autopsy specimens and radiographic evaluation have shown a clear association between increasing age and progressive disc degeneration.6 In a study of 1000 consecutive autopsies, Heine7 showed that disc degeneration increased linearly from 0% to 72% between the ages of 39 and 70 years. Another study based on histologic sections of the disc found annular tears in 30-year-olds and nuclear clefts in 40-year-olds.8 More recent studies have shown that degenerative changes can occur in the younger years. Histopathologic results from autopsy and surgical samples revealed annular tears and endplate cartilage pathology in 3- to 10-year-old children. Although there were significant variations in all age groups, the increase in degenerative scores was linear between 2 and 88 years of age.9 In studies using MRI, disc signal intensity also decreases with increasing age.2


The relationship of sex to disc degeneration is more complicated. In a review article of 600 autopsy specimens, Miller et al10 concluded that discs in men started to degenerate a decade earlier than discs in women and were more degenerated than age-matched discs in women. A recent article on sexual differences in degenerative disorders reported that although “degenerative changes are observed at similar rates in both sexes, women seem to be more susceptible to degenerative changes that lead to instability and malalignment.”11 Some biochemical metabolites such as insulin growth factor binding protein 1 and calcium hemostasis factors have been shown to be associated with decreased disc space loss in women.12 Clearly other factors, including genetics, play a role in the sexual variability seen in disc degeneration.


Environmental and Behavioral Factors

Many have suspected that heavy physical loading, related to occupation or sport, contributes to disc degeneration, but not all studies have supported this hypothesis.6,1316 The inconsistency in this body of literature is common in epidemiologic studies. Interestingly, some physical activities are viewed as harmful in the occupational literature, but beneficial in the sports medicine literature. No dose-response relationship between physical loading and disc degeneration has been clearly demonstrated. For example, in a study on weightlifters, 26 years of weightlifting could only explain 10% of the variability in disc degeneration compared with shooters who reported minimal time weightlifting.17 In addition, heavy physical loading in occupations may be related to lower socioeconomic status, youth, or lifestyle factors, further confounding the interpretation of this body of literature. The causal role of driving and whole-body vibration, previously accepted as a risk factor for disc degeneration,6 has also been called into question.14 In a series of studies on exposure-discordant monozygotic (MZ) twins (to reduce confounding variables), exposures suspected of accelerating disc degeneration, such as heavy physical loading, resistance training, and driving, were consistently shown to have minimal effects on degeneration.13,14,18


An association between cigarette smoking and back disorders, including degenerative discs, has been promulgated by many authors.1924 Some have even espoused a dose-response relationship.23,24 For example, Kelsey et al23 reported an increased risk of developing a herniated disc of 20% for each 10 cigarettes smoked per day in the previous year (odds ratio [OR] = 1.2), but not all studies have confirmed this association. Battie et al20 assessed lumbar MRI scans in MZ twins highly discordant for lifetime smoking history (mean of 32 pack-years) and could only explain 2% of the variance in disc degeneration. In another similar study, no significant association was found between smoking and disc degeneration.13


Genetic Factors

Previously, environmental factors were thought to play the primary role in disc degeneration and only recently has the importance of genetic factors been appreciated. In the Finnish twin cohort, environmental factors were thought to explain more than 80% of the etiology of sciatica.25 In 1995, the first two studies of familial aggregation of disc degeneration in MZ twins were published.13,26 The one study demonstrated similar degenerative findings according to spinal level compared with what would be expected by chance alone.26 The other study evaluated MRI scans in 115 male MZ twins to determine the relative effects of age, familial aggregation, and common exposures that were thought to be risk factors for disc degeneration.13 In the T12-L4 region, 61% of the variability in disc degeneration summary scores could be explained by familial aggregation, compared with 7% for physical loading and 9% for age. In the L4-S1 region, 34% of the variability in disc degeneration summary scores could be explained by familial aggregation, compared with 2% for physical loading and 7% for age. More of the variability in degeneration in the lower lumbar area remained unexplained. This, coupled with the fact that discs in the L4-S1 region are more degenerated than were those in the L1-L4 region, suggests that other unexplained variables have a disproportionate role in disc pathogenesis, affecting the lower lumbar levels more than the upper.


To distinguish between biologic and social sources of familial similarity, Sambrook et al27 performed a classic study using MRI scans from 86 pairs of MZ twins and 154 pairs of dizygotic (DZ) twins. Heritability estimates for summary scores of degeneration in the lumbar spine were 74% (95% confidence interval [CI], 64 to 80%), after adjusting for age, weight, smoking, occupation, and physical activity. Disc bulging and disc height, not signal intensity, were the major determinants of the degenerative summary scores.


Disc degeneration is not synonymous with back pain or disc herniation. Some family and twin studies make a convincing case that disc herniations are influenced by familial factors, including genetics. In studies of juveniles with disc herniations, the risk of developing a disc herniation before the age of 21 was 4 to 6 times higher for patients with a positive family history.28 Even adults undergoing surgery for disc herniations were 16.5 times more likely to have a family history of symptomatic disc herniations29 and tended to have more severe disc degeneration on MRI.30 Finally, in a classic study of 9000 Finnish twin pairs, the heritability estimate was 11% for hospitalization due to disc herniation.25


Although a substantial genetic influence on disc degeneration exists, the involved genes and pathophysiologic mechanisms have not been completely elucidated. Disc degeneration, like osteoarthritis, is best classified as a common, oligogenic, multifactorial disease. More than half a dozen gene loci have been associated with disc degeneration, mostly from chromosomes 2, 4, 6, 7, 11, 16, 19, and X, but those representing the most significant genetic susceptibility have yet to be identified.2


Most of the genes, except for the vitamin D receptor, associated with disc degeneration code for molecules that are involved in maintaining the structural integrity of the disc. Vitamin D receptor is a steroid nuclear receptor that is better known for its role in bone mineralization and calcium hemostasis. The TaqI and FokI polymorphisms have been associated with reduced disc signal intensity in lumbar and thoracic discs in a study of MZ Finnish twins.31 This association has been confirmed in both the Japanese32 and Chinese33 populations. There is an age-dependent correlation with higher odds ratio in younger individuals.32,33 Interestingly, the frequency of the risk t-allele is different among the different populations, 8% in Asians, 31% in Africans, and 43% in Caucasians.34


The only other genes, whose association with disc degeneration has been verified in different ethnic populations, are COL9A2 and COL9A3, which encode collagen IX. The tryptophan positive allele (Trp2) has been shown to be present in individuals with disc degeneration in both Finnish35 and Chinese36 populations. It is an age-dependent risk factor and is associated with structural changes, such as annular tears (OR = 2.4) and endplate herniations (OR = 4.0).36 Another mutation, the Trp3 allele, increases the risk of disc degeneration 3 times in the Finnish cohort,37 but is absent in the Chinese.36 This suggests that risk factors vary between different ethnic groups.


There are many other genes that have been studied but have less convincing data. In the Japanese population, more severe degeneration has been linked to shorter numbers of tandem repeats in the aggrecan gene,38 to specific genotypes of the matrix metalloproteinase-3 gene,39 and to mutations in the cartilage intermediate layer protein.40 A recent Chinese study linked polymorphisms in the matrix metalloproteinase-2 gene to disc degeneration (OR = 3.08).41 A study in the Dutch population showed that a collagen I gene (COL1A1) was also associated with disc degeneration, but the cohort was small.42 In the Finnish population, interleukin-1 (IL-1) gene mutations were associated with disc bulges (OR = 3.0),43 and further study showed that IL-1 modifies the effects of the COL9A3 polymorphism on disc degeneration.44 The genes and genetic mechanisms involved in disc degeneration are incredibly complex; additional study is needed to clarify the contribution of genetics to the pathophysiology of disc degeneration.


Economics


Health care costs continue to rise at astronomical rates, and technological advances continue to outpace our ability to pay for them. In 2005, total national health expenditures in the United States were $2 trillion, which represents 16% of the gross domestic product, and are expected to rise to $4 trillion by 2015 (20% of gross domestic product).45 There has been a 500% increase in spending in lumbar spine fusion surgery from 1992 to 2003 ($75 million to $482 million, respectively),46 and the total costs of low back pain exceed $100 billion per year.47 With the increased use of instrumentation and a broadening patient base, it is estimated that the spine market will compound at 22% annually.48


Determining the value of treatments and whether or not they improve the health of the population is the cornerstone of health economics. As costs rise and reimbursements fall, it is increasingly important that economic factors are included when evaluating treatment options. Unfortunately, there is a lack of well-designed and methodologically sound economic studies in the literature, and most surgeons are not familiar with basic health care economic principles. Currently, most studies address the economic impact of low back pain, which is too extensive to review here, and do not differentiate between the different diagnoses that can cause back pain.49,50 Interpreting these studies is difficult because patients with different diagnoses, but similar procedures may have very different outcomes.


Luo et al51 performed one of the only studies that correlated health expenditures to different diagnoses causing back pain. They used data from the 1998 Medical Expenditure Panel Survey, a national survey on health care utilization and expenditures. The most common diagnoses were unspecified back disorders (59.5%), back sprains and strains (16.2%), and IVD disorders (14.2%). Individuals with disc disorders had the highest per-capita total expenditures ($6010.70), while those with unspecified back disorders and back sprains were much lower ($3514 and $2494, respectively). For individuals with disc disorders, inpatient care expenditures per capita reached $2816, compared with only $634 for back sprains. Patients with disc disorders incurred much higher per-capita expenditures than individuals with other diagnoses.


For herniated discs, data from both the United States52 and Sweden53 have shown discectomy to be cost-effective, but the studies on lumbar fusion for degenerative disc disease are more controversial. Soegaard and Christensen54 in a literature review from 1997 to 2004 determined that most studies had questionable methodologies, studied different populations, and used different outcome measures; thus, they could not draw any general conclusions about the cost-effectiveness of lumbar arthrodesis. Only the study by Fritzell et al55 satisfied all of their methodological criteria and was limited to fusions for spondylosis. They determined that the spinal fusion group had better outcomes compared with the nonoperative group but higher costs, and therefore, lumbar fusion could be cost-effective depending upon the value put on the extra effect units gained by using surgery. In 2005, a randomized controlled trial in the United Kingdom concluded that spinal fusion was not a cost-effective use of scarce health care resources, but this could change if patients in the rehabilitation group required surgery in the future.56 Unfortunately, this study included all patients with chronic back pain for more than 12 months and was not limited to just degenerative disc disease. The lack of adequate data to evaluate the economic benefit of lumbar fusion surgery for disc degeneration led Polly et al57 to perform a cost-benefit analysis of lumbar fusion compared with other surgical interventions. They included patients with single-level degenerative disc disease that had participated in prospective multicenter trials conducted between 1995 and 2004 and concluded that “lumbar fusion cost per benefit achieved was very comparable to other well-accepted medical interventions (total hip replacement, total knee replacement, and coronary artery bypass surgery).” Even though this “thought experiment” included data from multiple other studies, it provided an important economic analysis, supporting lumbar fusion for degenerative disc disease.


In an environment with rising health care costs and diminishing resources, economic analyses are becoming increasingly important in assessing the utility of surgical procedures. In the future, study designs will need to include sound economic methodologies to help guide decisions regarding the most appropriate and efficient use of health care resources.


References


1. Frymoyer JW. Lumbar disk disease: epidemiology. Instr Course Lect 1992;41:217–223


2. Battie MC, Videman T, Parent E. Lumbar disc degeneration: epidemiology and genetic influences. Spine 2004;29(23):2679–2690


3. Thompson JP, Pearce RH, Schechter MT, Adams ME, Tsang IK, Bishop PB. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine 1990;15(5):411–415


4. Frobin W, Brinckmann P, Kramer M, Hartwig E. Height of lumbar discs measured from radiographs compared with degeneration and height classified from MR images. Eur Radiol 2001;11(2): 263–269


5. Shao Z, Rompe G, Schiltenwolf M. Radiographic changes in the lumbar intervertebral discs and lumbar vertebrae with age. Spine 2002;27(3):263–268


6. Andersson GB. The epidemiology of spinal disorders. In: Frymoyer JW, ed. The Adult Spine: Principles and Practice. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1997:93–141


7. Heine J. Uber die Arthritis deformans. Virch Arch Pathol Anat 1926;260:521–663


8. Coventry MB, Ghormley RK, Kernohan JW. The intervertebral disc: its microscopic anatomy and pathology, II: Changes in the intervertebral disc concomitant with age. J Bone Joint Surg Am 1945;27:233–247


9. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. 2002 Volvo Award in Basic Science. Classification of age-related changes in lumbar intervertebral discs. Spine 2002;27(23): 2631–2644


10. Miller JA, Schmatz C, Schultz AB. Lumbar disc degeneration: correlation with age, sex, and spine level in 600 autopsy specimens. Spine 1988;13(2):173–178


11. Manson NA, Goldberg EJ, Andersson GB. Sexual dimorphism in degenerative disorders of the spine. Orthop Clin North Am 2006; 37(4):549–553


12. Manek NJ, MacGregor AJ. Epidemiology of back disorders: prevalence, risk factors, and prognosis. Curr Opin Rheumatol 2005; 17(2):134–140


13. Battie MC, Videman T, Gibbons LE, Fisher LD, Manninen H, Gill K. 1995 Volvo Award in Clinical Sciences. Determinants of lumbar disc degeneration: a study relating lifetime exposures and magnetic resonance imaging findings in identical twins. Spine 1995;20(24):2601–2612


14. Battie MC, Videman T, Gibbons LE, et al. Occupational driving and lumbar disc degeneration: a case-control study. Lancet 2002; 360(9343):1369–1374


15. Frymoyer JW, Newberg A, Pope MH, Wilder DG, Clements J, MacPherson B. Spine radiographs in patients with low-back pain: an epidemiological study in men. J Bone Joint Surg Am 1984;66(7): 1048–1055


16. Savage RA, Whitehouse GH, Roberts N. The relationship between the magnetic resonance imaging appearance of the lumbar spine and low back pain, age and occupation in males. Eur Spine J 1997;6(2):106–114


17. Videman T, Sarna S, Battie MC, et al. The long-term effects of physical loading and exercise lifestyles on back-related symptoms, disability, and spinal pathology among men. Spine 1995;20(6):699–709


18. Videman T, Battie MC, Gibbons LE, et al. Lifetime exercise and disk degeneration: an MRI study of monozygotic twins. Med Sci Sports Exerc 1997;29(10):1350–1356


19. Battie MC, Bigos SJ, Fisher LD, et al. A prospective study of the role of cardiovascular risk factors and fitness in industrial back pain complaints. Spine 1989;14(2):141–147


20. Battie MC, Videman T, Gill K, et al. 1991 Volvo Award in Clinical Sciences. Smoking and lumbar intervertebral disc degeneration: an MRI study of identical twins. Spine 1991;16(9):1015–1021


21. Boshuizen HC, Verbeek JH, Broersen JP, Weel AN. Do smokers get more back pain? Spine 1993;18(1):35–40


22. Deyo RA, Bass JE. Lifestyle and low-back pain. The influence of smoking and obesity. Spine 1989;14(5):501–506


23. Kelsey JL, Githens PB, O’Conner T, et al. Acute prolapsed lumbar intervertebral disc. An epidemiologic study with special reference to driving automobiles and cigarette smoking. Spine 1984;9(6):608–613


24. Svensson HO, Vedin A, Wilhelmsson C, Andersson GB. Low-back pain in relation to other diseases and cardiovascular risk factors. Spine 1983;8(3):277–285


25. Heikkila JK, Koskenvuo M, Heliovaara M, et al. Genetic and environmental factors in sciatica: evidence from a nationwide panel of 9365 adult twin pairs. Ann Med 1989;21(5):393–398


26. Battie MC, Haynor DR, Fisher LD, Gill K, Gibbons LE, Videman T. Similarities in degenerative findings on magnetic resonance images of the lumbar spines of identical twins. J Bone Joint Surg Am 1995; 77(11):1662–1670


27. Sambrook PN, MacGregor AJ, Spector TD. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum 1999;42(2):366–372


28. Varlotta GP, Brown MD, Kelsey JL, Golden AL. Familial predisposition for herniation of a lumbar disc in patients who are less than twenty-one years old. J Bone Joint Surg Am 1991;73(1):124–128


29. Richardson JK, Chung T, Schultz JS, Hurvitz E. A familial predisposition toward lumbar disc injury. Spine 1997;22(13):1487–1492 discussion 1493


30. Matsui H, Kanamori M, Ishihara H, Yudoh K, Naruse Y, Tsuji H. Familial predisposition for lumbar degenerative disc disease: a case-control study. Spine 1998;23(9):1029–1034


31. Videman T, Leppavuori J, Kaprio J, et al. Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine 1998;23(23):2477–2485


32. Kawaguchi Y, Kanamori M, Ishihara H, Ohmori K, Matsui H, Kimura T. The association of lumbar disc disease with vitamin-D receptor gene polymorphism. J Bone Joint Surg Am 2002;84-A(11):2022–2028


33. Cheung KM, Chan D, Karppinen J, et al. Association of the Taq I allele in vitamin D receptor with degenerative disc disease and disc bulge in a Chinese population. Spine 2006;31(10):1143–1148


34. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338(2):143–156


35. Annunen S, Paassilta P, Lohiniva J, et al. An allele of COL9A2 associated with intervertebral disc disease. Science 1999;285(5426): 409–412


36. Jim JJ, Noponen-Hietala N, Cheung KM, et al. The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration. Spine 2005;30(24): 2735–2742


37. Paassilta P, Lohiniva J, Goring HH, et al. Identification of a novel common genetic risk factor for lumbar disk disease. JAMA 2001; 285(14):1843–1849


38. Kawaguchi Y, Osada R, Kanamori M, et al. Association between an aggrecan gene polymorphism and lumbar disc degeneration. Spine 1999;24(23):2456–2460


39. Takahashi M, Haro H, Wakabayashi Y, Kawa-uchi T, Komori H, Shinomiya K. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg Br 2001;83(4):491–495


40. Seki S, Kawaguchi Y, Chiba K, et al. A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nat Genet 2005;37(6):607–612


41. Dong DM, Yao M, Liu B, Sun CY, Jiang YQ, Wang YS. Association between the -1306C/T polymorphism of matrix metalloproteinase-2 gene and lumbar disc disease in Chinese young adults. Eur Spine J2007;16(11):1958–1961


42. Pluijm SM, van Essen HW, Bravenboer N, et al. Collagen type I alpha1 Sp1 polymorphism, osteoporosis, and intervertebral disc degeneration in older men and women. Ann Rheum Dis 2004;63(1): 71–77


43. Solovieva S, Kouhia S, Leino-Arjas P, et al. Interleukin 1 polymorphisms and intervertebral disc degeneration. Epidemiology 2004; 15(5):626–633


44. Solovieva S, Lohiniva J, Leino-Arjas P, et al. Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. Eur Spine J 2006;15(5):613–619


45. Health Insurance Cost. National Coalition on Health Care web site. Available at: www.nchc.org/facts/cost.shtml. Accessed August 23, 2007


46. Genuario JW, Mehta S, Nunley RM, The Washington Health Policy Fellows. Discrepancy in healthcare utilization: Is more better in orthopedic surgery? The American Academy of Orthopedic Surgeons web site. Available at: http://www.aaos.org/news/bulletin/jun07/reimbursement2.asp. Accessed August 23, 2007


47. Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am 2006;88(Suppl 2): 21–24


48. Lieberman IH. Disc bulge bubble: spine economics 101. Spine J 2004;4(6):609–613


49. Pai S, Sundaram LJ. Low back pain: an economic assessment in the United States. Orthop Clin North Am 2004;35(1):1–5


50. van der Roer N, Goossens ME, Evers SM, van Tulder MW. What is the most cost-effective treatment for patients with low back pain? A systematic review. Best Pract Res Clin Rheumatol 2005;19(4):671–684


51. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 2004;29(1):79–86


52. Malter AD, Larson EB, Urban N, Deyo RA. Cost-effectiveness of lumbar discectomy for the treatment of herniated intervertebral disc. Spine 1996;21(9):1048–1054 discussion 1055


53. Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J 2007;16(3):329–337


54. Soegaard R, Christensen FB. Health economic evaluation in lumbar spinal fusion: a systematic literature review anno 2005. Eur Spine J 2006;15(8):1165–1173


55. Fritzell P, Hagg O, Jonsson D, Nordwall A. Cost-effectiveness of lumbar fusion and nonsurgical treatment for chronic low back pain in the Swedish Lumbar Spine Study: a multicenter, randomized, controlled trial from the Swedish Lumbar Spine Study Group. Spine 2004;29(4):421–434 discussion Z423


56. Rivero-Arias O, Campbell H, Gray A, Fairbank J, Frost H, Wilson-MacDonald J. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. BMJ 2005;330(7502):1239


57. Polly DW Jr, Glassman SD, Schwender JD, et al. SF-36 PCS benefit-cost ratio of lumbar fusion comparison to other surgical interventions: a thought experiment. Spine 2007; 32(11, Suppl)S20-S26


Stay updated, free articles. Join our Telegram channel

Mar 25, 2017 | Posted by in NEUROSURGERY | Comments Off on The Epidemiology and Economics of Intervertebral Disc Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access